- Drugs
- Tuesday, 17 Sep 2019
Aphria Inc.'s Jamaican Subsidiary, Marigold, Receives Retail Herb House Licence
Aphria Inc. announced that its subsidiary Marigold Projects Jamaica Limited ("Marigold") has received a retail Herb House license from Jamaica's Cannabis Licensing Authority ("CLA") to open its first store in Kingston, Jamaica.
Aphria, Inc. is engaged in the production and supply of medical cannabis. It operates through three reportable segments including cannabis operations, distribution operations, and business under development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois. The Company is also engaged in the research and development, and commercial production of cannabis oil. The company was founded by Cole Cacciavillani and John Cervini on June 22, 2011 and is headquartered in Leamington, Canada. Aphria’s subsidiaries include Pure Natures Wellness Inc. that are engaged in the production and distribution of medical marijuana, and Cannway Pharmaceuticals Ltd., which specializes in offering support services to veterans and their first responders.
Related Industry Updates
Empty Capsules Market is?expected reach US$ 12.52 billion by 2030
Feb 01, 2024
ACG Inspection Introduces Groundbreaking Blockchain-based Brand Platform
Feb 07, 2020
Radiopharmaceutical Theragnostics Market is expected to reach US$ 3,441.97 million by 2028
Mar 27, 2023
Microbiome Therapeutics Market is expected to reach US$ 813.38 million by 2030
Nov 08, 2023
The ITC Complaint Against Estar Medical in the U.S. Is Withdrawn by Regenlab
Mar 05, 2020
Parenteral Nutrition Market is expected to reach US$ 11.12 billion by 2030
Feb 01, 2024
Australia & South Korea Diabetic Foot Ulcer Market is expected to reach US$ 313.53 billion by 2030
Sep 20, 2023